Expansion into Emerging Markets with High Prevalence of Chronic Inflammatory Conditions Presenting Lucrative Opportunities ...

Kronos Bio has announced a major restructuring, including significant workforce reductions, as it grapples with clinical and ...

UK-based drugmaker Advanz Pharma has announced that following the grant of a temporary suspension, as announced on last month ...

Prime Minister Pham Minh Chinh on November 28 received visiting Minister-President of Germany’s State of Hesse Boris Rhein, ...

In cases involving unpredictable factors, such as most chemical reactions, pharmaceutical activity, and physiological ...

China approved AstraZeneca Plc’s blockbuster breast cancer treatment for reimbursement by state-run medical insurance, a move that will boost the British drugmaker’s sales in the country in the midst ...

The collaboration includes a phase 1 clinical study to start in the second quarter of 2025. The National Skin Centre Singapore, Sanofi, and the Agency for Science, Technology, and Research (A*STAR) ...

The Life Insurance Corporation of India (LIC), a household name from bustling cities to remote villages, holds a special ...

The biggest threat for European pharmaceutical groups currently comes from the United States. President-elect Donald Trump ...

Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Singapore's and Saudi Arabia's health officials have signed a memorandum of understanding to strengthen health sector ...

The Prix Galien USA Best Startup category recognizes outstanding innovation by therapeutics-focused life science companies that have not yet received their first product approval The award to CervoMed ...